DR.REDDY'S LABORATORIES LTD.

DR.REDDY'S LABORATORIES LTD. - Clarification

Download	< Back
17 Feb 2017
Dr Reddys Laboratories Ltd has informed BSE as under:<BR><BR>"This is with reference to your email dated February 16, 2017, seeking clarification about the press release made by the Company on February 16, 2017, titled Dr. Reddy's announces US district court's opinion relating to patent infringement.<BR><BR>In this regard, we would like to state that there are no claims against the Company for monetary damages because the proposed palonosetron product has not been marketed.<BR><BR>As for quantum of claims, the claims only sought injunctive relief against the Company to prohibit the manufacturing, use, import and sale of the Companys palonosetron product prior to expiration of the patents-in-suit. Therefore, the Company believes there is no monetary compensation or penalty damages owed to Helsinn due to this decision."
View all announcements for DR.REDDY'S LABORATORIES LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us